dataService

您的位置: 首页 > 数据服务 > 数据列表页

筛选

共检索到12条 ,权限内显示50条;

Data from: Rapid quantitative pharmacodynamic imaging by a novel method: theory, simulation testing and proof of principle
负责人:
关键词:
fMRI;pharmacological fMRI;pharmacodynamics;phMRI;drug development;EC50;pharmacokinetic-pharmacodynamic modeling;ED50;neuroimaging;dose-finding
DOI:
doi:10.5061/dryad.s3443
摘要:
a novel method called rapid quantitative pharmacodynamic imaging. This method combines pharmacokinetic-pharmacodynamic modeling, repeated small doses
Data from: Preclinical toxicity and pharmacokinetics of a new orally bioavailable flubendazole formulation and the impact for clinical trials and r
负责人:
Lammens, Lieve
关键词:
pharmacokinetics flubendazole toxicity risk/benefit
DOI:
doi:10.5061/dryad.5vv774m
摘要:
ous solid dispersion (ASD) formulation was developed. As this formulation results in improved systemic absorption, the pharmacokinetic and toxicological profile
Data from: Developmental expression of drug metabolizing enzymes: impact on disposition in neonates and young children
负责人:
关键词:
Xenobiotic Metabolizing Enzymes;human;Hepatic;Cytochrome P450;Sulfotransferase;Glutathione S-Transferase;Flavin Monooxygenase;UDP Glucuronosyltransferase;Homo Sapiens;ontogeny
DOI:
doi:10.5061/dryad.71pp6
摘要:
-dependent changes in other physiological factors impacting drug disposition, can be integrated into physiologically-based pharmacokinetic models. Such models ha
Data from: Increased dystrophin production with golodirsen in patients with Duchenne muscular dystrophy
负责人:
关键词:
golodirsen;Neuromuscular Disease;Muscle disease
DOI:
doi:10.5061/dryad.g003051
摘要:
Objective To report safety, pharmacokinetics, exon 53 skipping, and dystrophin expression in golodirsen-treated pati
Data from: Targeting antibiotic resistant bacteria with phages reduces bacterial density in an insect host
负责人:
Mikonranta, Lauri
关键词:
antibiotic resistance bacteriophage gut infection insect model phage therapy
DOI:
doi:10.5061/dryad.sc54383
摘要:
d pharmacokinetic effects on both phage and antibiotic dynamics compared to in vitro: antibiotics did not reduce the overall amount of bacteria, demonstrati
Data from: Biophysically inspired model for functionalized nanocarrier adhesion to cell surface: roles of protein expression and mechanical factors
负责人:
关键词:
tissue targeting;cell membrane;entropy loss upon binding;functionalized nanocarriers;pharmacodynamic model;free energy landscape
DOI:
doi:10.5061/dryad.4h76d
摘要:
mechanisms that govern their capture by the target cell. Next-generation pharmacokinetic (PK) models that systematically account for proteomic and mechanic
Data from: Randomized phase 2 study of FcRn antagonist efgartigimod in generalized myasthenia gravis
负责人:
关键词:
Clinical Neurology;Clinical Trials;Myasthenia;Autoimmune diseases;Neuromuscular Disease
DOI:
doi:10.5061/dryad.4hk2039
摘要:
Myasthenia Gravis Quality of Life scale), pharmacokinetics, pharmacodynamics, and immunogenicity. Results: Of the 35 screened patients, 24 were enrolled and r
Data from: Spectroscopic and molecular docking studies reveal binding characteristics of nazartinib (EGF816) to human serum albumin
负责人:
关键词:
Nazartinib;EGF816;human serum albumin;fluorescence quenching
DOI:
doi:10.5061/dryad.05c6v93
摘要:
tely gained considerable attention due to the significant influence of such interactions on the pharmacokinetics and/or -dynamics of this important class
Antimalarial activity, toxicity, pharmacokinetics and metabolic drug interaction of Plumbago Indica linn.
负责人:
Kesara Na-Bangchang, Advisor
关键词:
Pharmacokinetics Plumbagin Antimalarial Plasmodium falciparum Plasmodium berghei Permeability Transport Efflux transporters Caco-2 cell P-glycoprotein
DOI:
doi:10.14457/tu.the.2015.159
摘要:
the pharmacokinetics and disposition of plumbagin in animal model.Results suggest that clinical relevance of the interference of human drug metabolizing enzymes should
Proinsulin-transferrin fusion protein as a liver targeting insulin therapeutic in Type 1 diabetes treatment
负责人:
关键词:
Pharmaceutical Sciences proinsulin-transferrin fusion protein liver targeting diabetes long-acting insulin therapeutic
DOI:
doi:10.25549/usctheses-c40-250950
摘要:
nd. ? Among a myriad of efforts in optimizing pharmacokinetic and pharmacodynamic (PK/PD) profiles of basal INS therapeutics, novel delivery devices applied

首页上一页12下一页尾页

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充